Navigation Links
Irvine Scientific Launches IS CHO-CD XP(TM)
Date:3/6/2009

SANTA ANA, Calif., March 6 /PRNewswire/ -- Irvine Scientific, a leading medical device/biopharmaceutical company located in Santa Ana, California, is proud to announce the addition of IS CHO-CD XP(TM) Culture System to their cell culture product line. IS CHO-CD XP(TM) Culture System is a set of chemically-defined*, serum-free, and animal component free media designed using metabolic-balancing technology to deliver robust cell growth and production for recombinant CHO cell lines. It supports batch, fed-batch, and perfusion culture processes.

The IS CHO-CD XP(TM) Culture System is made up of IS CHO-CD XP(TM) growth medium, IS CHO Feed-CD XP medium, and IS Hydrolysate Blend XP(TM) supplement. All components are fully compatible with other IS CHO products and are available in liquid or powder formats.

With over three decades of life-science innovation Irvine Scientific has expertise in developing world-class cell culture media for the biopharmaceutical industry. They are industrial-scale media manufacturers with a capacity of 800,000 kg/yr (~40 million liters) and continue to be leaders in rapid turnaround time worldwide. Irvine Scientific's ongoing personal service, technical support, and accessibility to key team members ensure that your questions and concerns are addressed every step of the way. Their cGMP facility was the first media manufacturing facility to receive ISO 13485:2003 certification. At Irvine Scientific their staff is virtually an extension of yours.

For more information on Irvine Scientific, visit our website at www.irvinesci.com/xp or contact: Nancy Huezo at nhuezo@irvinesci.com. Phone (800) 437-5706 or (949) 261-7800 ext 238.

*Chemically-defined when used without the Hydrolysate Blend.

    Contact:    Nancy Huezo
                Associate Product Manager
                800 437 5706 / 949 261 7800 ext 238
                nhuezo@irvinesci.com


'/>"/>
SOURCE Irvine Scientific
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
2. BioMed Realty Trust Appoints Executive Officer of the Irvine Company to Its Board
3. Families of Spinal Muscular Atrophy; University of California, Irvine Stem Cell Scientist; and California Stem Cell Announce Collaboration for Safety Studies for Stem Cell Therapy in Spinal Muscular Atrophy
4. Irvine Dermatologist Begins In-office Clinical Studies -- Nissan Pilest, MD Combines Multi-Use Botox in Laser Resurfacing Clinical Studies
5. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
6. Thermo Fisher Scientific Executive Officers Adopting SEC Rule 10b5-1 Trading Programs
7. Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend
8. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
9. Boston Scientific Amends Credit Facility and Prepays $1 Billion on Loan
10. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
11. Thermo Fisher Scientific to Present at Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Alto, CA, USA (PRWEB) , ... October 11, 2017 , ... ... set to take place on 7th and 8th June 2018 in San Francisco, CA. ... policy influencers as well as several distinguished CEOs, board directors and government officials from ...
(Date:10/11/2017)... , Oct. 11, 2017  VMS BioMarketing, a leading provider ... nationwide oncology Clinical Nurse Educator (CNE) network, which will launch ... for communication among health care professionals to enhance the patient ... office staff, and other health care professionals to help women ... cancer. ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions are the main ... people each year. Especially those living in larger cities are affected by air pollution ... of the most pollution-affected countries globally - decided to take action. , “I knew ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
Breaking Biology Technology:
(Date:4/5/2017)... April 5, 2017  The Allen Institute for Cell ... Explorer: a one-of-a-kind portal and dynamic digital window into ... data, the first application of deep learning to create ... cell lines and a growing suite of powerful tools. ... these and future publicly available resources created and shared ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/29/2017)... the health IT company that operates the largest health ... today announced a Series B investment from BlueCross BlueShield ... investment and acquisition accelerates higi,s strategy to create the ... activities through the collection and workflow integration of ambient ... secures data today on behalf of over 36 million ...
Breaking Biology News(10 mins):